Benign Prostatic Hyperplasia
Benign prostatic hyperplasia which is also known as prostate gland enlargement is a condition that affects men as they get older. When the prostate is enlarged, it can result in problems with the urinary tract which include the blockage of the urine flow out of the bladder and this can lead to bladder or kidney issues. It is however important to note that Benign Prostatic Hyperplasia (BPH) is not cancerous as it is often miscommunicated. The prostate doesn’t stop growing and it undergoes two growth periods; the first one takes place during puberty while the second one begins during adulthood. It is very likely for people with penises to experience benign prostatic hyperplasia during the second growth period. This condition starts with the enlarging of the prostate which can result in the thickening of the bladder wall. As a result, the bladder may become weak and lose the function to empty; and this is when BPH starts to set in. The prostate is very crucial to the fertility of men and so the treatment of conditions related to it should be conducted carefully. The cause of this condition is still a bit vague but as earlier mentioned, it mostly affects older men. However, it has been argued that this condition can be caused by the reduction in the production of testosterone and the increase in the production of estrogen as men age. This may be your first time hearing about this condition, but it is the most common prostate issue that men, who are above fifty, face. This condition can also be hereditary; people with heart disease, and type 2 diabetes are more likely to develop this condition. If left untreated, it can lead to complications such as bladder damage, kidney damage, bladder stones, and bloody urine.
How BPH can be treated with PEMF Therapy
Pulsed Electro-Magnetic Field Therapy (PEMF) is one of the non-invasive procedures that can be administered to treat benign prostatic hyperplasia. PEMF therapy uses magnetic energy to boost cells, improve cell communication, and remodel tissues. It is therefore not surprising that it can be used to treat BPH. Although, there are few instances whereby PEMF therapy has been performed on patients for research, but these instances have recorded high success rates and the prostrate size of the patients reduced significantly after 28 days of undergoing the therapy. Also, patients with no underlying conditions such as high blood pressure, high blood sugar, and so on, benefited more and healed quickly compared to the patients that had these conditions. It is important to note that patients who have not confirmed whether they have prostate cancer should not undergo this therapy. Also, because pulsed electro-magnetic field therapy increases blood circulation, it can help to prevent secondary complications as well.
For more information, the initial study of the effectiveness of PEMF therapy was conducted on dogs for five minutes each day. This therapy was a huge success on the dogs and this inspired the researchers to try it out on men. It worked, but it was slower, compared to how rapidly the dogs recovered. These researches promise better success rates and hope for people who suffer from benign prostatic hyperplasia. This is because medications only slightly improve and manage these conditions, and, it is believed that with proper research and study, PEMF therapy can be more sustainable and dependable.
Medications are not sustainable in the long run and PEMF therapy is still under research; because of this, it is important that men should be aware of their reproductive health status and should actively try to work towards improving their lifestyle habits. Some of the complications of the conditions (bladder stones, bladder damage, kidney stones, and so on) can turn out to be extremely serious and life-threatening.
Conclusion
Benign prostatic hyperplasia is a condition that mostly affects elderly men who are in the second prostate development stage. The cause is currently unknown but has been traced to a drop in testosterone levels in men. In addition, the complications may get worse if left untreated. As a result of the lack of sustainability of drugs, in this case, PEMF therapy has been regarded to be a better and safer alternative. Although it is still under study, the research conducted on it has been largely successful and this brings hope to doctors in this field and patients who are suffering from this condition. It is important to note that benign prostatic hyperplasia is not cancerous. It is also important for men who are liable to suffer from this condition to live and lead healthier lives to reduce their chances.
